Theriva Biologics
TOVX
45 hedge funds and large institutions have $70.2M invested in Theriva Biologics in 2015 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 2 reducing their positions, and 7 closing their positions.
700% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 2
100% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 7
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
15% more funds holding
Funds holding: 39 → 45 (+6)
0% more ownership
Funds ownership: 0% → 0% (+0%)
1% less capital invested
Capital invested by funds: $70.6M → $70.2M (-$357K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TS
Third Security
Radford,
Virginia
|
+$2.63M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
+$2.02M |
| 3 |
MP
MSD Partners
New York
|
+$1.75M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.65M |
| 5 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
+$1.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$531K |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$159K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$123K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$82K |
| 5 |
Jane Street
New York
|
-$70K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1 | – | – | – |
|
|
52
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| – | -$531K | -21 | Closed |
|
|
TC
53
TFS Capital
West Chester,
Pennsylvania
| – | -$159K | -6 | Closed |
|
|
54
Dimensional Fund Advisors
Austin,
Texas
| – | -$82K | -3 | Closed |
|
|
55
Jane Street
New York
| – | -$70K | -3 | Closed |
|
|
RCM
56
Rotella Capital Management
Bellevue,
Washington
| – | -$58K | -2 | Closed |
|
57
Verition Fund Management
Greenwich,
Connecticut
| – | -$42K | -2 | Closed |
|
58
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$29K | -1 | Closed |
|
59
Walleye Trading
New York
| – | -$6K | – | – |
|
TOVX Hedge Fund Activity: Q3 2015 in Review
45 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Theriva Biologics (TOVX) for Q3 2015, worth a combined $70.2M — down 0.51% from $70.6M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new TOVX positions and 7 closed out — a net gain of 7 holders — while 16 added to existing stakes and 2 trimmed.
The largest buyer was Third Security, adding an estimated $2.63M. The largest seller was Janney Montgomery Scott, exiting entirely with an estimated $531K sold.
- 45 institutional investors held Theriva Biologics (TOVX) as of Q3 2015, up from 39 in Q2 2015.
- Funds reported $70.2M of Theriva Biologics stock for Q3 2015, down 0.51% quarter-over-quarter.
- 14 funds opened new Theriva Biologics positions in Q3 2015 and 7 closed out, a net change of +7 holders.
- The largest Theriva Biologics buyer in Q3 2015 was Third Security, an estimated $2.63M added.
- The largest Theriva Biologics seller in Q3 2015 was Janney Montgomery Scott, an estimated $531K sold.
Based on aggregated 13F filings for Q3 2015.